108 related articles for article (PubMed ID: 36911994)
1. Utility of Retrospective Molecular Analysis in Diagnostically Challenging Mesenchymal Neoplasms.
Mindiola Romero AE; Tafe LJ; Green DC; Deharvengt SJ; Winnick KN; Tsongalis GJ; Baker ML; Linos K; Levy JJ; Kerr DA
Int J Surg Pathol; 2023 Dec; 31(8):1473-1484. PubMed ID: 36911994
[No Abstract] [Full Text] [Related]
2. Fusion of old and new: Employing touch imprint slides for next generation sequencing in solid tumors.
Aydin Mericoz C; Eren OC; Kulac I; Firat P
Diagn Cytopathol; 2024 May; 52(5):264-270. PubMed ID: 38339821
[TBL] [Abstract][Full Text] [Related]
3. Factors Impacting Clinically Relevant RNA Fusion Assays Using Next-Generation Sequencing.
Ramani NS; Patel KP; Routbort MJ; Alvarez H; Broaddus R; Chen H; Rashid A; Lazar A; Lucas FAS; Yao H; Manekia J; Dang H; Barkoh BA; Medeiros LJ; Luthra R; Roy-Chowdhuri S
Arch Pathol Lab Med; 2021 Nov; 145(11):1405-1412. PubMed ID: 33493304
[TBL] [Abstract][Full Text] [Related]
4. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
[TBL] [Abstract][Full Text] [Related]
5. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
[TBL] [Abstract][Full Text] [Related]
6. Utilization of cytology smears improves success rates of RNA-based next-generation sequencing gene fusion assays for clinically relevant predictive biomarkers.
Ramani NS; Chen H; Broaddus RR; Lazar AJ; Luthra R; Medeiros LJ; Patel KP; Rashid A; Routbort MJ; Stewart J; Tang Z; Bassett R; Manekia J; Barkoh BA; Dang H; Roy-Chowdhuri S
Cancer Cytopathol; 2021 May; 129(5):374-382. PubMed ID: 33119213
[TBL] [Abstract][Full Text] [Related]
7. Targeted capture-based NGS is superior to multiplex PCR-based NGS for hereditary BRCA1 and BRCA2 gene analysis in FFPE tumor samples.
Zakrzewski F; Gieldon L; Rump A; Seifert M; Grützmann K; Krüger A; Loos S; Zeugner S; Hackmann K; Porrmann J; Wagner J; Kast K; Wimberger P; Baretton G; Schröck E; Aust D; Klink B
BMC Cancer; 2019 Apr; 19(1):396. PubMed ID: 31029168
[TBL] [Abstract][Full Text] [Related]
8. Calling Chromosome Alterations, DNA Methylation Statuses, and Mutations in Tumors by Simple Targeted Next-Generation Sequencing: A Solution for Transferring Integrated Pangenomic Studies into Routine Practice?
Garinet S; Néou M; de La Villéon B; Faillot S; Sakat J; Da Fonseca JP; Jouinot A; Le Tourneau C; Kamal M; Luscap-Rondof W; Boeva V; Gaujoux S; Vidaud M; Pasmant E; Letourneur F; Bertherat J; Assié G
J Mol Diagn; 2017 Sep; 19(5):776-787. PubMed ID: 28826610
[TBL] [Abstract][Full Text] [Related]
9. Evaluating melanocytic lesions with single nucleotide polymorphism (SNP) chromosomal microarray.
Hedayat AA; Linos K; Jung HS; Tafe LJ; Yan S; LeBlanc RE; Lefferts JA
Exp Mol Pathol; 2017 Dec; 103(3):279-287. PubMed ID: 29169801
[TBL] [Abstract][Full Text] [Related]
10. Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiences.
Cho M; Ahn S; Hong M; Bang H; Van Vrancken M; Kim S; Lee J; Park SH; Park JO; Park YS; Lim HY; Kang WK; Sun JM; Lee SH; Ahn MJ; Park K; Kim DH; Lee S; Park W; Kim KM
Oncotarget; 2017 Jun; 8(26):42478-42486. PubMed ID: 28477007
[TBL] [Abstract][Full Text] [Related]
11. [Feasibility of amplicon-based targeted next-generation sequencing of colorectal cancer in endoscopic biopsies].
Wang YJ; Jiang RR; Liu HJ; Zhang B; Ye F; Bu H
Zhonghua Bing Li Xue Za Zhi; 2018 Jul; 47(7):499-504. PubMed ID: 29996313
[No Abstract] [Full Text] [Related]
12. Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis.
Tan AC; Lai GGY; Tan GS; Poon SY; Doble B; Lim TH; Aung ZW; Takano A; Tan WL; Ang MK; Tan BS; Devanand A; Too CW; Gogna A; Ong BH; Koh TPT; Kanesvaran R; Ng QS; Jain A; Rajasekaran T; Lim AST; Lim WT; Toh CK; Tan EH; Lim TKH; Tan DSW
Lung Cancer; 2020 Jan; 139():207-215. PubMed ID: 31835042
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic Impact of Next-Generation Sequencing Panels for Lymphoproliferative Neoplasms on Small-Volume Biopsies.
Fei F; Natkunam Y; Zehnder JL; Stehr H; Gratzinger D
Am J Clin Pathol; 2022 Sep; 158(3):345-361. PubMed ID: 35552630
[TBL] [Abstract][Full Text] [Related]
14. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
Andersson C; Fagman H; Hansson M; Enlund F
Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
[TBL] [Abstract][Full Text] [Related]
15. Multicenter validation of cancer gene panel-based next-generation sequencing for translational research and molecular diagnostics.
Hirsch B; Endris V; Lassmann S; Weichert W; Pfarr N; Schirmacher P; Kovaleva V; Werner M; Bonzheim I; Fend F; Sperveslage J; Kaulich K; Zacher A; Reifenberger G; Köhrer K; Stepanow S; Lerke S; Mayr T; Aust DE; Baretton G; Weidner S; Jung A; Kirchner T; Hansmann ML; Burbat L; von der Wall E; Dietel M; Hummel M
Virchows Arch; 2018 Apr; 472(4):557-565. PubMed ID: 29374318
[TBL] [Abstract][Full Text] [Related]
16. The clinical utility of next-generation sequencing for bone and soft tissue sarcoma.
Gusho CA; Weiss MC; Lee L; Gitelis S; Blank AT; Wang D; Batus M
Acta Oncol; 2022 Jan; 61(1):38-44. PubMed ID: 34686105
[No Abstract] [Full Text] [Related]
17. Clinical mutational profiling of bone metastases of lung and colon carcinoma and malignant melanoma using next-generation sequencing.
Zheng G; Lin MT; Lokhandwala PM; Beierl K; Netto GJ; Gocke CD; Eshleman JR; McCarthy E; Illei PB
Cancer Cytopathol; 2016 Oct; 124(10):744-753. PubMed ID: 27286239
[TBL] [Abstract][Full Text] [Related]
18. Targeted Next-Generation Sequencing Validates the Use of Diagnostic Biopsies as a Suitable Alternative to Resection Material for Mutation Screening in Colorectal Cancer.
Ham-Karim HA; Ebili HO; Manger K; Fadhil W; Ahmad NS; Richman SD; Ilyas M
Mol Diagn Ther; 2019 Jun; 23(3):383-393. PubMed ID: 30741375
[TBL] [Abstract][Full Text] [Related]
19. Using "residual" FNA rinse and body fluid specimens for next-generation sequencing: An institutional experience.
Wei S; Lieberman D; Morrissette JJ; Baloch ZW; Roth DB; McGrath C
Cancer Cytopathol; 2016 May; 124(5):324-9. PubMed ID: 26682952
[TBL] [Abstract][Full Text] [Related]
20. The utility and limitation of single nucleotide polymorphism analysis on whole genome amplified mesenchymal tumour DNA in formalin fixed tumour samples.
Liang CW; Lee YS; Marino-Enriquez A; Tsui K; Huang SH
Pathology; 2012 Jan; 44(1):33-41. PubMed ID: 22157688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
